SCHEMBL5847570

SCHEMBL5847570

OC1(c2ccccc2)CCN(CCCCn2cc3ccccc3n2)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.55
DRD2 P14416 5/20 0.51
CCR3 P51677 1/20 0.49
OPRL1 P41146 2/20 0.49
HTR1A P08908 3/20 0.48
DRD4 P21917 3/20 0.48
HTR2A P28223 3/20 0.48
DRD3 P35462 3/20 0.48
HTR7 P34969 2/20 0.48
SLC6A4 P31645 1/20 0.48
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.46
CCR1 P32246 1/20 0.45
LTA4H P09960 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5847009 0.91 DRD2 (0.52) SIGMAR1DRD2HTR1ADRD4HTR2A
SCHEMBL5846990 0.76 SIGMAR1 (0.59) SIGMAR1DRD2CCR3OPRL1MEN1
SCHEMBL5848148 0.76 CCR3 (0.58) SIGMAR1DRD2CCR3OPRL1POLB
SCHEMBL5849042 0.75 SIGMAR1 (0.58) SIGMAR1DRD2CCR3OPRL1MEN1
SCHEMBL9370237 0.74 SIGMAR1 (0.72) SIGMAR1DRD2CCR3OPRL1MEN1
SCHEMBL5847565 0.73 DRD2 (0.59) SIGMAR1DRD2CCR3OPRL1DRD4
SCHEMBL5847154 0.73 P2RX7 (0.59) SIGMAR1DRD2CCR3OPRL1MEN1
SCHEMBL11062805 0.73 SIGMAR1 (0.70) SIGMAR1DRD2CCR3OPRL1MEN1
SCHEMBL7233756 0.73 SIGMAR1 (0.70) SIGMAR1DRD2CCR3OPRL1MEN1
SCHEMBL11778752 0.73 SIGMAR1 (0.70) SIGMAR1DRD2CCR3OPRL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39113-E1 Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2006-05-30 US claimed
EP-0721455-B9 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2005-04-20 EP claimed
EP-1097698-B1 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN ESTEVE LABOR DR (ES) 2003-05-07 EP claimed
EP-0721455-B1 TETRAHYDROPYRIDINE-(OR 4-HYDROXYPIPERIDINE)ALKYLAZOLES HAVING AN AFFINITY FOR SIGMA AND/OR 5HT1A RECEPTORS ESTEVE LABOR DR (ES) 2002-12-11 EP claimed
EP-1097698-A2 UTILIZATION OF DERIVATIVES OF TETRAHYDROPYRIDINES (OR 4-HYDROXYPIPERIDINES)-BUTYLAZOLS IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-05-09 EP claimed
CN-1166173-A Tetrahydropyridine- (or 4-hydroxypiperidine) alkylpyrroles active at sigma and/or 5HTIA receptors ESTEVE S A LAB DE DR (ES) 1997-11-26 CN claimed